- Home
- CLIR vs TVRD Comparison
CLIR vs TVRD Comparison
Compare CLIR & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLIR | TVRD |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.4M | 37.3M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLIR | TVRD |
|---|---|---|
| Price | $0.72 | $4.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $2.00 | ★ $51.67 |
| AVG Volume (30 Days) | ★ 147.0K | 137.6K |
| Earning Date | 11-14-2025 | 02-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,153,000.00 | N/A |
| Revenue This Year | $13.13 | N/A |
| Revenue Next Year | $143.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.46 | $3.74 |
| 52 Week High | $1.53 | $43.65 |
Technical Indicators
Market Signals| Indicator | CLIR | TVRD |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 57.60 |
| Support Level | $0.63 | $4.39 |
| Resistance Level | $0.81 | $4.76 |
| Average True Range (ATR) | 0.08 | 0.33 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 59.00 | 92.17 |
Price Performance
Historical ComparisonAbout CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About TVRD Tvardi Therapeutics Inc.
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.